Earnings

Stock Earnings on Trader’s Radar: Boston Scientific Corporation (NYSE:BSX)

Shares of Boston Scientific Corporation (NYSE:BSX) fell -1.56% to reach at $22.09 during previous trading session. The company has experienced volume of 18.70M shares while on average the company has a capacity of trading 8.41M share.

Boston Scientific Corporation (NYSE:BSX) on October 26, 2016 reported that its generated sales of $2.105 billion during the third quarter ended September 30, 2016, compared to the company’s guidance range for the quarter of $2.035 to $2.085 billion. This represents growth of 11 percent on a reported basis and 10 percent on an operational basis (calculated on a constant currency basis), all compared to the prior year period. The company reported GAAP earnings of $228 million, or $0.17 per share, compared to a loss of $(0.15) a year ago, and achieved adjusted earnings per share of $0.27 for the period, compared to $0.24 a year ago.

On a consolidated GAAP basis, net income for the third quarter of 2016 was $228 million, or $0.17 per share. These results included an intangible asset impairment charge, acquisition-related net credits, restructuring and restructuring-related net charges, litigation-related net charges and amortization expense, of $140 million (after-tax) or $0.10 per share. Adjusted net income for the third quarter of 2016, excluding these net charges, was $368 million, or $0.27 per share.

On a consolidated GAAP basis, net loss for the third quarter of 2015 was $198 million, or $(0.15) per share. These results included intangible asset impairment charges, acquisition-related net charges, restructuring and restructuring-related net charges, litigation-related net charges, pension termination charges and amortization expense, of $524 million (after-tax) or $0.39 per share. Adjusted net income for the third quarter of 2015, excluding these net charges, was $326 million, or $0.24 per share.

Boston Scientific Corporation (NYSE:BSX) holds the market capitalization of $29.37B along with 1.36B outstanding shares. During the last trade, stock’s minimum price has been reached out at $21.82 while the maximum trading price moved at $22.54. Currently the stock price is moving -10.89% off from the highest level of twelve months and +40.97% above from twelve months low. Boston Scientific Corporation (NYSE:BSX) marked 52-week highest price level of $24.79 on 07/28/16 and 52-week lowest price level of $15.67 on 02/08/16. For the stock, price target value has been calculated at $27.57 based on calls of 22 experts. Stock’s minimum price target estimates has been figured out at $22.00 while the maximum price target forecast is established at $31.00.

As of current trade, Boston Scientific Corporation (NYSE:BSX) has shown weekly downbeat performance of -3.41%. Its six months performance indicated a bullish movement while its yearly performance reflected a positive trend of 31.33%. Year-to-date (YTD) performance of the stock illustrate upbeat trend of 19.79%. Shares of Boston Scientific Corporation (NYSE:BSX) currently have an ABR of 1.63, derived from a total of 19 opinions. The company’s price sits -6.41% below from its 50-day moving average of $23.37 and 3.47% above from the stock’s 200-day moving average of $22.94. The company has Relative Strength Index (RSI 14) of 31.47 along with Average True Range (ATR 14) of 0.41. Its weekly and monthly volatility is 1.92%, 1.71% respectively. The company’s beta value is at 1.13.

Boston Scientific Corporation (NYSE:BSX)’s price to sales ratio for trailing twelve months is 3.81 and price to book ratio for most recent quarter is 4.82, whereas price to cash per share for the most recent quarter is 69.20. Boston Scientific Corporation (NYSE:BSX)’s price to free cash flow for trailing twelve months is 42.27. Its quick ratio for most recent quarter is 0.70 along with current ratio for most recent quarter of 1.00. Total debt to equity ratio of the company for most recent quarter is 0.87 whereas long term debt to equity ratio for most recent quarter is 0.83. Boston Scientific Corporation (NYSE:BSX) has a Return on Assets of -1.90%. The company currently has a Return on Equity of -5.40% and Return on Investment of 0.70%.

Previous ArticleNext Article

Leave a Reply